The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
Open accessAbstract
The 13th St Gallen International Breast Cancer Conference (2013) Expert Panel reviewed and endorsed substantial new evidence on aspects of the local and regional therapies for early breast cancer, supporting less extensive surgery to the axilla and shorter durations of radiation therapy. It refined its earlier approach to the classification and management of luminal disease in the absence of amplification or overexpression of the Human Epidermal growth factor Receptor 2 (HER2) oncogene, while retaining essentially unchanged recommendations for the systemic adjuvant therapy of HER2-positive and 'triple-negative' disease. The Panel again accepted that conventional clinico-pathological factors provided a surrogate subtype classification, while noting that in those areas of the world where multi-gene molecular assays are readily available many clinicians prefer to base chemotherapy decisions for patients with luminal disease on these genomic results rather than the surrogate subtype definitions. Several multi-gene molecular assays were recognized as providing accurate and reproducible prognostic information, and in some cases prediction of response to chemotherapy. Cost and availability preclude their application in many environments at the present time. Broad treatment recommendations are presented. Such recommendations do not imply that each Panel member agrees: indeed, among more than 100 questions, only one (trastuzumab duration) commanded 100% agreement. The various recommendations in fact carried differing degrees of support, as reflected in the nuanced wording of the text below and in the votes recorded in supplementary Appendix S1, available at Annals of Oncology online. Detailed decisions on treatment will as always involve clinical consideration of disease extent, host factors, patient preferences and social and economic constraints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Self-citationGoldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Self-citationGiuliano, A. E. (2011) · JAMA · doi:10.1001/jama.2011.90 · Cited by 2,942
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Self-citationvon Minckwitz, G., Untch, M., Blohmer, J.-U., Costa, S. D., Eidtmann, H., Fasching, P. A., Gerber, B., Eiermann, W., Hilfrich, J., Huober, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.8595 · Cited by 2,659
Self-citationPaik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
Self-citationEarly Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,089
Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., Abraham, M., Alencar, V. H. M., Badran, A., Bonfill, X., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61963-1 · Cited by 2,044
Self-citationDowsett, M., Nielsen, T. O., A'Hern, R., Bartlett, J., Coombes, R. C., Cuzick, J., Ellis, M., Henry, N. L., Hugh, J. C., Lively, T., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr393 · Cited by 1,977
Self-citationLong-Term Results of Hypofractionated Radiation Therapy for Breast Cancer
Whelan, T. J., Pignol, J.-P., Levine, M. N., Julian, J. A., MacKenzie, R., Parpia, S., Shelley, W., Grimard, L., Bowen, J., Lukka, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906260 · Cited by 1,878
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
Self-citationDenkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Self-citationLoi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Self-citationAlbain, K. S., Barlow, W. E., Shak, S., Hortobagyi, G. N., Livingston, R. B., Yeh, I.-T., Ravdin, P., Bugarini, R., Baehner, F. L., Davidson, N. E., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70314-6 · Cited by 1,407
Self-citationGalimberti, V., Cole, B. F., Zurrida, S., Viale, G., Luini, A., Veronesi, P., Baratella, P., Chifu, C., Sargenti, M., Intra, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70035-4 · Cited by 1,233
Self-citationWhole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
de Azambuja, E., Cardoso, F., de Castro, G., Colozza, M., Mano, M. S., Durbecq, V, Sotiriou, C., Larsimont, D., Piccart-Gebhart, M. J., & Paesmans, M. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603756 · Cited by 959
Self-citationWirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2124 · Cited by 891
Smith, B. D., Arthur, D. W., Buchholz, T. A., Haffty, B. G., Hahn, C. A., Hardenbergh, P. H., Julian, T. B., Marks, L. B., Todor, D. A., Vicini, F. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.031 · Cited by 872
Self-citationBreast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., Downey, R. J., Manova-Todorova, K., Brogi, E., & Massagué, J. (2011) · Nature Medicine · doi:10.1038/nm.2379 · Cited by 869 · cited 1×
“In preclinical models, tenascin C promotes the aggressiveness of metastasis [41] and autocrine tenascin”
BackgroundNielsen, T. O., Parker, J. S., Leung, S., Voduc, D., Ebbert, M., Vickery, T., Davies, S. R., Snider, J., Stijleman, I. J., Reed, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1282 · Cited by 801
Self-citationMavaddat, N., Barrowdale, D., Andrulis, I. L., Domchek, S. M., Eccles, D., Nevanlinna, H., Ramus, S. J., Spurdle, A., Robson, M., Sherman, M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0775 · Cited by 669
Dowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A., A'Hern, R., Salter, J., Detre, S., Hills, M., & Walsh, G. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk020 · Cited by 665
Self-citationPolgár, C., Limbergen, E. V., Pötter, R., Kovács, G., Polo, A., Lyczek, J., Hildebrandt, G., Niehoff, P., Guinot, J. L., Guedea, F., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.01.014 · Cited by 633
Gianni, L., Zambetti, M., Clark, K., Baker, J., Cronin, M., Wu, J., Mariani, G., Rodriguez, J., Carcangiu, M., Watson, D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0818 · Cited by 626
Amir, E., Seruga, B., Niraula, S., Carlsson, L., & Ocaña, A. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr242 · Cited by 622
Ibrahim, Y. H., García-García, C., Serra, V., He, L., Torres-Lockhart, K., Prat, A., Anton, P., Cozar, P., Guzmán, M., Grueso, J., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0348 · Cited by 601
Prat, A., Cheang, M. C. U., Martín, M., Parker, J. S., Carrasco, E., Caballero, R., Tyldesley, S., Gelmon, K., Bernard, P. S., Nielsen, T. O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4134 · Cited by 587
Self-citationAdjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
Muss, H. B., Berry, D. A., Cirrincione, C. T., Theodoulou, M., Mauer, A. M., Kornblith, A. B., Partridge, A. H., Dressler, L. G., Cohen, H. J., Becker, H. P., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810266 · Cited by 554
Self-citationGoldhirsch, A., Gelber, R. D., Piccart-Gebhart, M. J., de Azambuja, E., Procter, M., Suter, T. M., Jackisch, C., Cameron, D., Weber, H. A., Heinzmann, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61094-6 · Cited by 497
Self-citationGnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Heck, D., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Pristauz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70122-x · Cited by 472
Self-citationJuvekar, A., Burga, L. N., Hu, H., Lunsford, E. P., Ibrahim, Y. H., Balmañà, J., Rajendran, A., Papa, A., Spencer, K., Lyssiotis, C. A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0336 · Cited by 465
Breast-Cancer Adjuvant Therapy with Zoledronic Acid
Coleman, R. E., Marshall, H., Cameron, D., Dodwell, D., Burkinshaw, R., Keane, M., Gil, M., Houston, S. J., Grieve, R. J., Barrett-Lee, P. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105195 · Cited by 424
Breast-cancer Adjuvant Therapy With Zoledronic Acid
Coleman, R. E., Marshall, H. C., Cameron, D., et al. (2011) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 413
Viale, G., Giobbie-Hurder, A., Regan, M. M., Coates, A. S., Mastropasqua, M. G., Dell'Orto, P., Maiorano, E., MacGrogan, G., Braye, S. G., Öhlschlegel, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0829 · Cited by 340
Self-citationColeman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., von Minckwitz, G., Sleeboom, H. P., Forbes, J., Barrios, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds277 · Cited by 339
Self-citationPivot, X., Romieu, G., Debled, M., Pierga, J.-Y., Kerbrat, P., Bachelot, T., Lortholary, A., Espié, M., Fumoleau, P., Serin, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70225-0 · Cited by 337
Jackson, J. G., Pant, V., Li, Q., Chang, L. L., Quintás-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.027 · Cited by 329
Luporsi, E., André, F., Spyratos, F., Martin, P.-M., Jacquemier, J., Penault-Llorca, F., Tubiana-Mathieu, N., Sigal-Zafrani, B., Arnould, L., Gompel, A., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1837-z · Cited by 320
Self-citationSestak, I., Distler, W., Forbes, J. F., Dowsett, M., Howell, A., & Cuzick, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2021 · Cited by 311
Self-citationExtracellular matrix components in breast cancer progression and metastasis
Oskarsson, T. (2013) · The Breast · doi:10.1016/j.breast.2013.07.012 · Cited by 289
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
Straver, M. E., Glas, A. M., Hannemann, J., Wesseling, J., van de Vijver, M. J., Rutgers, E. J. T., Vrancken Peeters, M.-J. T. F. D., van Tinteren, H., van‘t Veer, L. J., & Rodenhuis, S. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0333-1 · Cited by 252
Self-citationViale, G., On the behalf of the International Breast Cancer Study Group, Regan, M. M., On the behalf of the International Breast Cancer Study Group, Mastropasqua, M. G., On the behalf of the International Breast Cancer Study Group, Maffini, F., On the behalf of the International Breast Cancer Study Group, Maiorano, E., On the behalf of the International Breast Cancer Study Group, et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm289 · Cited by 247
Self-citationMirza, A. N., Mirza, N. Q., Vlastos, G., & Singletary, S. E. (2002) · Annals of Surgery · doi:10.1097/00000658-200201000-00003 · Cited by 246
Locoregional recurrence risk after lipofilling in breast cancer patients
Petit, J. Y., Botteri, E., Lohsiriwat, V., Rietjens, M., De Lorenzi, F., Garusi, C., Rossetto, F., Martella, S., Manconi, A., Bertolini, F., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr158 · Cited by 239
Self-citationBuckland, G., Travier, N., Cottet, V., González, C. A., Luján‐Barroso, L., Agudo, A., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Peeters, P. H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.27958 · Cited by 238
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Ellis, M. J., & Perou, C. M. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0462 · Cited by 229
Self-citationAge-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover
Clarke, C. A., Keegan, T. H. M., Yang, J., Press, D. J., Kurian, A. W., Patel, A. H., & Lacey, J. V. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs264 · Cited by 228
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
Drukker, C. A., Bueno‐de‐Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Roumen, R. M. H., Knauer, M., van 't Veer, L. J., Sonke, G. S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28082 · Cited by 227
Self-citationPfeiler, G., Königsberg, R., Fesl, C., Mlineritsch, B., Stoeger, H., Singer, C. F., Pöstlberger, S., Steger, G. G., Seifert, M., Dubsky, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.2585 · Cited by 221
Self-citationDubsky, P., Filipits, M., Jakesz, R., Rudas, M., Singer, C. F., Greil, R., Dietze, O., Luisser, I., Klug, E., Sedivy, R., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds334 · Cited by 212
Self-citationNiraula, S., Ocana, A., Ennis, M., & Goodwin, P. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2073-x · Cited by 189
Self-citationTrihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Self-citationNutrition and physical activity influence on breast cancer incidence and outcome
Chlebowski, R. T. (2013) · The Breast · doi:10.1016/j.breast.2013.07.006 · Cited by 156
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
Bailey, S. T., Shin, H., Westerling, T., Liu, X. S., & Brown, M. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018858109 · Cited by 156
Axillary Dissection Versus No Axillary Dissection in Older Patients With T1N0 Breast Cancer
Martelli, G., Boracchi, P., Ardoino, I., Lozza, L., Böhm, S., Vetrella, G., & Agresti, R. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31827660a8 · Cited by 152
Cheang, M. C. U., Voduc, K. D., Tu, D., Jiang, S., Leung, S. C. Y., Chia, S., Shepherd, L. E., Levine, M. N., Pritchard, K. I., Davies, S. R., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2956 · Cited by 143
Self-citationPrat, A., Parker, J. S., Fan, C., Cheang, M. C. U., Miller, L. D., Bergh, J. C. S., Chia, S., Bernard, P. S., Nielsen, T. O., Ellis, M. J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds080 · Cited by 141
Self-citationEwertz, M., Gray, K. P., Regan, M. M., Ejlertsen, B., Price, K. N., Thurlimann, B. J. K., Bonnefoi, H. R., Forbes, J., Paridaens, R., Rabaglio, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8666 · Cited by 133
Self-citationBonnefoi, H. R., Piccart, M. J., Bogaerts, J., Mauriac, L., Fumoleau, P., Brain, E. G. C., Petit, T., Rouanet, P., Jassem, J., Blot, E., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70094-8 · Cited by 131
Self-citationSex hormones and breast cancer risk and prognosis
Folkerd, E. J., & Dowsett, M. (2013) · The Breast · doi:10.1016/j.breast.2013.07.007 · Cited by 131
Hassett, M. J., Silver, S. M., Hughes, M. E., Blayney, D. W., Edge, S. B., Herman, J. G., Hudis, C. A., Marcom, P. K., Pettinga, J., Share, D. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.5740 · Cited by 130
Self-citationFolkerd, E. J., Dixon, J. M., Renshaw, L., A’Hern, R., & Dowsett, M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.0273 · Cited by 119
Klang, S. H., Hammerman, A., Liebermann, N., Efrat, N., Doberne, J., & Hornberger, J. C. (2010) · Value in Health · doi:10.1111/j.1524-4733.2010.00724.x · Cited by 116
Tsoi, D. T. F., Inoue, M., Kelly, C. M., Verma, S., & Pritchard, K. I. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0275 · Cited by 109
Self-citationPinto, A. C., Ades, F., de Azambuja, E., & Piccart, M. J. (2013) · The Breast · doi:10.1016/j.breast.2013.07.029 · Cited by 107
MIB-1 labelling index is an independent prognostic marker in primary breast cancer
Jansen, R. L. H., Hupperets, P. S. G. J., Arends, J. W., Joosten-Achjanie, S., Volovics, A., Schouten, H. C., & Hillen, H. F. P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.515 · Cited by 106
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Livingston, R. B., Davidson, N. E., Perez, E. A., Chávarri-Guerra, Y., Cameron, D., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds330 · Cited by 94
Self-citationKiess, A. P., McArthur, H. L., Mahoney, K., Patil, S. N., Morris, P. G., Ho, A. Y., Hudis, C. A., & McCormick, B. L. (2011) · Cancer · doi:10.1002/cncr.26484 · Cited by 92
Self-citationAdipose tissue cells, lipotransfer and cancer: A challenge for scientists, oncologists and surgeons
Bertolini, F., Lohsiriwat, V., Petit, J., & Kolonin, M. G. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.004 · Cited by 91
TP53 Status and Response to Treatment in Breast Cancers
Varna, M., Bousquet, G., Plassa, L., Bertheau, P., & Janin, A. (2011) · BioMed Research International · doi:10.1155/2011/284584 · Cited by 87
Hall, P. S., McCabe, C. J., Stein, R. C., & Cameron, D. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr484 · Cited by 80
Is Adjuvant Chemotherapy Useful for Women With Luminal A Breast Cancer?
Coates, A. S., Colleoni, M. A., & Goldhirsch, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.7879 · Cited by 67
Self-citationAssociation between breast cancer subtypes and response to neoadjuvant anastrozole
Dunbier, A. K., Anderson, H., Ghazoui, Z. F., Salter, J., Parker, J. S., Perou, C. M., Smith, I. E., & Dowsett, M. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.025 · Cited by 60
Self-citationKerbel, R. S., Guérin, É., Francia, G., Xu, P., Lee, C. R., Ebos, J. M. L., & Man, S. (2013) · The Breast · doi:10.1016/j.breast.2013.07.011 · Cited by 43
Developing an Effective Breast Cancer Vaccine
Soliman, H. H. (2010) · Cancer Control · doi:10.1177/107327481001700307 · Cited by 42
Who should not undergo breast conservation?
Nijenhuis, M. V., & Rutgers, E. J. T. (2013) · The Breast · doi:10.1016/j.breast.2013.07.021 · Cited by 31
Self-citationAdipose tissue and breast cancer progression: A link between metabolism and cancer
Bertolini, F. (2013) · The Breast · doi:10.1016/j.breast.2013.07.009 · Cited by 20
From genome to bedside: Are we lost in translation?
Hayes, D. F. (2013) · The Breast · doi:10.1016/j.breast.2013.07.004 · Cited by 13
Self-citationCurigliano, G., Criscitiello, C., Espósito, A., Fumagalli, L. A. M., Gelao, L., Locatelli, M., Minchella, I., & Goldhirsch, A. (2013) · The Breast · doi:10.1016/j.breast.2013.07.018 · Cited by 11
Self-citationHypofractionation in the era of modulated radiotherapy (RT)
Mouw, K. W., & Harris, J. R. (2013) · The Breast · doi:10.1016/j.breast.2013.07.024 · Cited by 9
Self-citationPartial breast irradiation: Targeting volume or breast molecular subtypes?
Orecchia, R., & Leonardi, M. C. (2013) · The Breast · doi:10.1016/j.breast.2013.07.025 · Cited by 9
Influence of genomics on adjuvant treatments for pre-invasive and invasive breast cancer
Abu-Khalaf, M. M., & Pusztai, L. (2013) · The Breast · doi:10.1016/j.breast.2013.07.015 · Cited by 7
Follow-up tests to detect recurrent disease: Patient's reassurance or medical need?
Smith, I. E., & Schiavon, G. (2013) · The Breast · doi:10.1016/j.breast.2013.07.030 · Cited by 6
Self-citation
Cited by
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Aebi, S., Davidson, T., Gruber, G., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq159 · Cited by 2,842
Triple-negative breast cancer molecular subtyping and treatment progress
Yin, L., Duan, J.-J., Bian, X.-W., & Yu, S.-C. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01296-5 · Cited by 2,452
Harbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
Self-citationEBCTCG (Early Breast Cancer Trialists' Collaborative Group) (2014) · The Lancet · doi:10.1016/s0140-6736(14)60488-8 · Cited by 2,254
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., Zackrisson, S., & Senkus, E. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz173 · Cited by 2,214
Self-citation
Metadata
- Authors
- Goldhirsch, A., Winer, E. P., Coates, A. S., Gelber, R. D., Piccart-Gebhart, M., Thürlimann, B., Senn, H.-J., Albain, K. S., André, F., Bergh, J., Bonnefoi, H., Bretel-Morales, D., Burstein, H., Cardoso, F., Castiglione-Gertsch, M., Coates, A. S., Colleoni, M., Costa, A., Curigliano, G., Davidson, N. E., Di Leo, A., Ejlertsen, B., Forbes, J. F., Gelber, R. D., Gnant, M., Goldhirsch, A., Goodwin, P., Goss, P. E., Harris, J. R., Hayes, D. F., Hudis, C. A., Ingle, J. N., Jassem, J., Jiang, Z., Karlsson, P., Loibl, S., Morrow, M., Namer, M., Kent Osborne, C., Partridge, A. H., Penault-Llorca, F., Perou, C. M., Piccart-Gebhart, M. J., Pritchard, K. I., Rutgers, E. J. T., Sedlmayer, F., Semiglazov, V., Shao, Z.-M., Smith, I., Thürlimann, B., Toi, M., Tutt, A., Untch, M., Viale, G., Watanabe, T., Wilcken, N., Winer, E. P., & Wood, W. C.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 24
- Issue
- 9
- Pages
- 2206-2223
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2117775530
- Cited by
- 3,746
- References
- 88
- FWCI
- 89.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.